Search

Your search keyword '"S. Pisegna"' showing total 28 results

Search Constraints

Start Over You searched for: Author "S. Pisegna" Remove constraint Author: "S. Pisegna"
28 results on '"S. Pisegna"'

Search Results

4. Zinc modulates c-Myc/Mad1 balance in human leukemia cells

5. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias

6. Author Correction: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.

7. Clinical implications of the Drug-Drug Interaction in Cancer Patients treated with innovative oncological treatments.

8. Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study.

9. Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort.

10. Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study.

11. PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey.

12. Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study.

13. The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma.

14. [Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.]

15. Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.

16. Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.

17. The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.

18. The Strange Case of a Pancreatic Neuroendocrine Carcinoma With Low Proliferation Index and Atypical Clinical Behavior.

19. Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?

20. Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments.

21. Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?

22. Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer.

23. Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer.

24. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells.

25. Zinc modulates c-Myc/Mad1 balance in human leukemia cells.

26. Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.

27. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

28. Detection of homozygous deletions of the cyclin-dependent kinase 4 inhibitor (p16) gene in acute lymphoblastic leukemia and association with adverse prognostic features.

Catalog

Books, media, physical & digital resources